Physician profile
Murray S Las
NPI 1114003928
$6,420.28
in general payments reported to CMS, 2019-2025
48 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,989 · 2020: $1,426 · 2021: $1,894 · 2022: $1,112.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,324.35 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $825.84 | 2019-2022 | |
| Lilly USA, LLC | $429.50 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $419.54 | 2019-2022 | |
| Amgen INC. | $372.22 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $355.58 | 2019-2021 | |
| Abbvie INC. | $314.41 | 2020-2022 | |
| Abbott Laboratories | $254.48 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $250.21 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.85 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $135.90 | 2019-2022 | |
| Ibsa Pharma INC. | $118.38 | 2019-2021 | |
| Medtronic Minimed, INC. | $101.36 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.82 | 2021-2022 | |
| Mannkind Corporation | $95.36 | 2019-2020 |
Show all 48 companies
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murray Las listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.